“episil gave me the relief I needed to be able to start eating properly”
Learn more

Oral mucositis affects

Head and neck cancer patients – over 90%
BMT patients – up to 80%
Chemotherapy patients – 40 to 75%

(Ref. 1-5)

Oral pain is common during cancer therapies

Oral pain associated with inflammation of the inside lining of the mouth is often a serious side effect of cancer treatments (radiation and chemotherapy). This oral condition is called oral mucositis (OM) and causes redness, mouth ulcers and sores that can be very painful and distressing. Oral pain can make it difficult to eat, drink, and even speak, affecting patients’ quality of life and their social and emotional well-being (Ref. 6).

Learn more

Introducing episil® oral liquid

Now there is episil® oral liquid – a treatment for intraoral pain caused by oral mucositis and other inflammatory conditions of the mouth that can help you continue to enjoy eating, drinking, socialising, and getting back to your daily routines. episil® oral liquid has been clinically demonstrated to provide significant oral pain relief that lasts for up to 8 hours, and has no known side effects. When applied in the mouth, episil® liquid forms a bioadhesive film that soothes and protects painful mouth ulcers and sores. The product is ready-to-use and relieves pain within 5 minutes of application (Ref. 7), so that you can eat, drink, and talk almost immediately.

Learn more
episil 10ml

Advantages of episil® oral liquid

  • Provides rapid and significant oral pain relief for up to 8 hours (Ref. 7)
  • Allows eating and drinking 5 minutes after application (Ref. 7)
  • Convenient, ready-to-use, pocket- sized device (Ref. 7, 8)
  • Increases cancer patient’s quality of life (Ref. 8)
How to use episil®
Obtain episil®